Clinical trial
Aspirin and Plavix Following Coronary Artery Bypass Grafting (ASAP-CABG)
NCT01158703 is registered in ClinicalTrials.gov with Ahmad Slim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aspirin and Plavix Following Coronary Artery Bypass Grafting (ASAP-CABG)
- Lead sponsor
- Ahmad Slim
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- July 31, 2010
- Completion date
- December 31, 2014
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary graft patency